Summary
Recent in vivo microdialysis studies have indicated that presynaptic deficits occur in brain 5-HT neurochemistry during cocaine withdrawal. The purpose of the present study was to utilize the head-twitch response (HTR) produced by 5-hydroxytryptophan (5-HTP) to investigate the dose- and time-response effects of this deficit. The HTR is considered to be a sensitive model for activation of central postsynaptic 5-HT2A receptors in rodents. Thus, different groups of mice were injected with cocaine twice daily (0, 0.1, 0.5, 2.5, 5 or 10mg/kg, i.p.) for 7 or 13 days. During HTR testing, at 24h following last injection, the treated mice received either 1) no cocaine; 2) their corresponding daily dose as challenge injection; or 3) a 10 mg/kg challenge dose. In a second series of experiments, extended abstinence studies were performed under the conditions of experimental protocols 1 and 2 for both 7- and 13-day cocaine (0, 0.5 and 5 mg/kg, twice daily) exposure regimens at 24, 48, 72 and 96 h following last cocaine injection. In protocol 3, the effects of a 10 mg/kg challenge dose of cocaine were studied following prolonged withdrawal from chronic cocaine exposure (0, 0.5, 5 and 10 mg/kg, twice daily for 7 and 13 days) at 24, 96 and 240 h abstinence. In experimental protocol 1 at 24 h abstinence in the 7 day exposure group, only lower doses of cocaine (0.5–2.5 mg/kg) significantly attenuated the 5-HTP-induced HTR. The deficit in 0.5 mg/kg group persisted up to 72 h abstinence. Although in the 13 day cocaine exposure groups (experimental paradigm 1) mean HTRs were generally reduced, they however failed to attain statistical significance throughout the 96 h abstinence. In protocol 2 very low challenge doses of cocaine (0.1–0.5 mg/kg) in their corresponding pretreatment groups significantly reduced the behavior at diverse abstinence intervals in both 7- and 13-day exposure regimens relative to their chronically vehicle-treated controls which had received a vehicle challenge injection during HTR testing. Unlike small doses of cocaine, larger challenge doses (5–10 mg/kg) of the stimulant potentiated the HTR score at various abstinence periods. However, the degree of the potentiations are considerably less than the ability of acute cocaine administration in enhancing the 5-HTP-induced HTR. The 10 mg/kg challenge injection in experimental protocol 3 at 24 h abstinence in the 7-day exposed mice attenuated the 5-HTP-induced HTR in 0.5, 5 and 10 mg/kg cocaine-treated groups relative to their chronic vehicle-treated controls receiving a 10 mg/kg challenge cocaine injection. The deficit in chronic 10 mg/kg cocaine-exposed mice persisted up to 240 h postcocaine abstinence. On the other hand, in the 13-day regimen, the challenge 10 mg/kg dose exhibited significant potentiations at 24 h and at 96 h for 5 and 0.5 mg/kg chronic cocaine doses respectively, but it also produced significant deficits in 0.5 and 10 mg/kg chronic doses of cocaine at 240 h abstinence. Overall, the present results suggest that enduring deficits occur in presynaptic serotonin neurochemistry and serotonergic adaptive mechanisms are exquisitely sensitive to chronic administration of low- and high-doses of cocaine.
Similar content being viewed by others
References
Batki SL, Manfredi LB, Jacob P, Jones RT (1993) Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharm 13: 243–250
Baumann MH, Rothman RB (1996) Chronic cocaine exposure potentiates prolactin and head-shake response to 5-HT2 receptor stimulation in rats. Neuropharmacology 35: 295–301
Baumann MH, Raley TJ, Partilla JS, Rothman RB (1993) Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study. Synapse 14: 40–50
Baumann MH, Becketts KM, Rothmann RB (1995) Evidence for alterations in presynaptic serotonergic function during withdrawal from chronic cocaine in rats. Eur J Pharmacol 282: 87–93
Black EW, Lakoski JM (1990) In vitro electrophysiology of dorsal raphe serotonergic neurons in subchronic cocaine-treated rats: development of tolerance to acute cocaine administration. Mol Cell Neurosci 1: 84–91
Bradberry CW, Nobiletti JB, Elsworth JD, Murphy D, Jatlow P, Roth RH (1993) Cocaine and cocalthylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 60: 1429–1435
Broderick PA, Kornak EP, Eng F, Wechler R (1993) Real time detection of acute (IP) cocaine-enhanced dopamine and serotonin release in ventrolateral nucleus accumbens of behaving Norway rat. Pharmacol Biochem Behav 46: 715–722
Buckland PR, Spurlock G, McGuffin P (1996) Amphetamine and vigabatrin down-regulate aromatic L-amino acid decarboxylase mRNA levels. Brain Res Mol: Brain Res 35: 69–76
Carroll ME, Lac ST, Asencio M, Kargh R (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35: 237–244
Cunningham KA (1995) Modulation of serotonin function by acute and chronic cocaine: neurophysiological analysis: In: Hammer RP Jr (ed) The neurobiology of cocaine: cellular and molecular mechanisms. CRC Press, Boca Raton Fl, pp 121–123
Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104: 177–180
Cunningham KA, Paris JM, Goeders NE (1992) Serotonin neurotransmission in cocaine sensitization. Ann NY Acad Sci 654: 117–127
Darmani NA (1996) Differential potentiation of L-tryptophan-induced head-twitch response in mice by cocaine and sertraline. Life Sci 59: 1109–1119
Darmani NA (1997a) Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice. Pharmacol Biochem Behav (in press)
Darmani NA (1997b) Withdrawal from chronic cocaine administration causes prolonged deficits in L-tryptophan-induced head-twitch response in mice. Life Sci 61: 1147–1158
Darmani NA (1997c) Deficits in d-fenfluramine-sensitive pool of brain 5-HT following withdrawal from chronic cocaine exposure. Life Sci 61: 2575–2582
Darmani NA, Reeves SL (1996) The stimulatory and inhibitory components of cocaine's actions on the 5-HTP-induced 5-HT1A-receptor function. Pharmacol Biochem Behav 55: 387–396
Darmani NA, Hadfield MG, Carter WH, Martin BR (1990) Acute and chronic effects of cocaine on isolation-induced aggression. Psychopharmacology 102: 37–40
Darmani NA, Martin BR, Pandey U, Glennon RA (1991) Inhibition of 5-HT2-receptor mediated head-twitch response by cocaine via indirect stimulation of adrenergic α2 and serotonergic 5-HT1A receptors. Pharmacol Biochem Behav 38: 353–357
Darmani NA, Martin BR, Glennon RA (1992) Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2-receptor function. Pharmacol Biochem Behav 41: 519–527
Darmani NA, Shaddy J, Gerdes CF (1996) Differential ontogenic regulation of three DOI-induced behaviours in mice. Physiol Behav 60: 1495–1500
Dworkin SI, Co C, Smith JE (1995) Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res 682: 116–126
Eble JP, Goodrich C (1987) The maturational onset of the 5-HT mediated head twitch in mice. Physiol Behav 41: 47–51
Fibiger HC, Miller JJ (1977) An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience 2: 975–987
Gartside SE, Cowen PJ, Sharp T (1992) Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 31: 9–14
Heal DJ, Luscombe GP, Martin KF (1992) Pharmacological characterization of 5-HT receptor subtypes using behavioral models. In: Marsden CA, Heal DJ (eds) Central serotonin receptors and psychotropic drugs. Blackwell, London, pp 56–99
Ichikawa J, Meltzer HY (1995) DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res 698: 204–208
Johanson CE, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41: 3–52
Kosten TA, Kosten TR, Gawin FH, Gorden LT, Hogan IS, Kleber HD (1992) An open trial of sertraline for cocaine abuse. Am J Addict 1: 349–353
Knapp S, Mandell AJ (1972) Narcotic drugs: effects on the serotonin biosynthetic systems of the brain. Science 177: 1209–1211
Kuhar MJ, Pilotte NS (1996) Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 17: 260–264
Levy AD, Rittenhouse PA, Li Q, Bonnadonna AM, Alvarez Sanz MC, Kerr JE, Betha CL, Van de Kar LD (1992) Repeated injections of cocaine inhibit the serotonergic regulation of prolactin and renin secretion in rats. Brain Res 580: 6–11
Levy AD, Li Q, Van de Kar LD (1994) Repeated cocaine exposure inhibits the adreno-corticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT. Neuropharmacology 33: 335–342
Loh EA, Roberts DCS (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101: 262–266
Moore RY, Halaris AE, Jones BE (1978) Serotonin neurons of the midbrain raphe: ascending projections. J Comp Neurol 180: 417–438
Murphy DL (1991) An overview of serotonin neurochemistry and neuroanatomy. In: Sandier M, Cooper A, Harnet S (eds) 5-Hydroxytryptamine in psychiatry: a spectrum of ideas. Oxford University Press, Oxford, pp 23–26
Palfreyman MG, Schmidt CJ, Sorensen SM, Dudley MW, Kehen JH, Moser P, Gittos MW, Carr AA (1993) Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function. Psychopharmacology 112 [Suppl 1]: S60-S67
Parsons LH, Justice JB Jr (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606: 195–199
Parsons LH, Koob GF, Weiss F (1995) Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 274: 1182–1191
Peltier R, Schenk S (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology 110: 390–394
Pollack MH, Rosenbaum JF (1991) Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiat 52: 31–33
Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46: 635–645
Roberts DCS, Loh EA, Baker GB, Vickers G (1994) Lesions of central serotonin system affect responding on a progressive ratio schedule reinforced by intravenous cocaine or by food. Pharmacol Biochem Behav 49: 177–182
Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112: 93–99
Walsh SL, Prestin KL, Sullivan JT, Fromne R, Bigelow GE (1994) Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharm 14: 396–407
Weiss F, Parsons LH, Markou A (1995) Neurochemistry of cocaine withdrawal. In: Hammer RP Jr (ed) The neurobiology of cocaine: cellular and molecular mechanisms. CRC Press, Boca Raton, pp 163–180
Yocca FD, Wright RN, Margraf RR, Eison AS (1990) 8-OH DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Pharmacol Biochem Behav 35: 1–4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Darmani, N.A., Shaddy, J. & Elder, E.L. Prolonged deficits in presynaptic serotonin function following withdrawal from chronic cocaine exposure as revealed by 5-HTP-induced head-twitch response in mice. J. Neural Transmission 104, 1229–1247 (1997). https://doi.org/10.1007/BF01294723
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01294723